Esketamine, a molecular relative of regular ... the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato, without ...

Esketamine (a derivative of ketamine) nasal spray formulations can act fast and help reduce dangerous symptoms of major depression and suicidal thoughts found a new study. The findings of this ...

Called Spravato, a brand name for esketamine, and developed by Johnson & Johnson, the drug is a nasal spray designed to treat severe forms of depression that don't respond to other medications.

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of Kloxxado (naloxone HCl) nasal spray 8 mg, by Health Canada for the treatment of ...

March 20, 2025 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by ...